speb/financial-data huggingface dataset:
Financial ratios for TXP.L — annual report dated 2023-12-31
Total revenue: 36486363.63636363
Gross profit: 22712121.21212121
Operating income: 7063636.363636363
Net income: -15604545.454545453
Capital expenditures: 14355303.03030303
Operating cash flow: 9653787.878787879
Depreciation & amortization: 4552272.727272727
Net tangible assets: 45277272.72727273
Owner earnings: -25407575.757575758
Return on net tangible assets (%): -56.115517183683025
Capex to operating income (%): 203.22822822822823
Buffett classification: The Gruesome
Stock price: 0.005443037974683544
Shares outstanding: 351364939
Book value: 45277272.72727273
P/B ratio: 0.04223957386897508
Market cap (USD): 1912492.705949367
Debt to equity: 0.5164307465783221
Current ratio: 0.7485655533813141
Quick ratio: 0.7455474113628072
Interest coverage ratio: 3.7177033492822966
COGS to revenue (%): 37.751754495245216
SG&A to revenue (%): 22.204227399194387
Free cash flow (dilution-adjusted): -5643181.818181818
Buyback yield (%): 0
Retained earnings: -36546212.12121212
Inventory turnover: 199.8021978021978
Receivables turnover: 3.7474323062558352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.570089248784434
FCF margin (%): -15.466550392425566
Revenue growth (%): 15.43631541770471
Rule of 40 score: -0.030234974720855234
Financial ratios for TXP.L — quarterly report dated 2024-09-30
Capital expenditures: 1937777.7777777778
Buffett classification: The Gruesome
Stock price: 0.0044
Shares outstanding: 351364939
Market cap (USD): 1546005.7316
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TXP.L — annual report dated 2024-12-31
Total revenue: 40232867.132867135
Gross profit: 23885314.685314685
Operating income: 7856643.356643357
Net income: 5784615.384615385
Capital expenditures: 16558741.25874126
Operating cash flow: 9217482.517482517
Depreciation & amortization: 6644055.944055945
Net tangible assets: 48131468.53146853
Owner earnings: -4130069.930069931
Return on net tangible assets (%): -8.58081013541001
Capex to operating income (%): 210.76101468624833
Buffett classification: The Gruesome
Stock price: 0.0031249999999999997
P/E ratio: 0.18981649796376326
Shares outstanding: 351364939
Book value: 48131468.53146853
P/B ratio: 0.022812838832397424
Market cap (USD): 1098015.434375
Debt to equity: 0.5689399662927879
Current ratio: 0.942194810718843
Quick ratio: 0.9385793279455551
Effective tax rate (%): -37.226277372262764
Interest coverage ratio: 3.9159986057859886
COGS to revenue (%): 40.63233274816193
SG&A to revenue (%): 20.410894617002416
Free cash flow (dilution-adjusted): -8452447.552447552
Buyback yield (%): 0
Retained earnings: -27950349.65034965
Inventory turnover: 275.0235294117647
Receivables turnover: 4.167547989858747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.725332587777546
FCF margin (%): -21.008812333791038
Revenue growth (%): 10.26822934135755
Rule of 40 score: -10.740582992433488
Financial ratios for TXP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0031249999999999997
Shares outstanding: 351364939
Market cap (USD): 1098015.434375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TXP.L — quarterly report dated 2025-03-31
Total revenue: 7780419.58041958
Gross profit: 4113286.7132867137
Operating income: 704895.1048951049
Net income: 28671.328671328672
Capital expenditures: 4370629.370629371
Operating cash flow: 3923776.223776224
Depreciation & amortization: 1696503.4965034965
Net tangible assets: 48356643.35664336
Owner earnings: -2645454.545454546
Return on net tangible assets (%): -5.470715835140999
Capex to operating income (%): 620.0396825396826
Buffett classification: The Gruesome
Stock price: 0.002727272727272727
P/E ratio: 8.355629646951218
Shares outstanding: 351364939
Book value: 48356643.356643364
P/B ratio: 0.01981667768763557
Market cap (USD): 958268.0154545454
Debt to equity: 0.5413593637020968
Current ratio: 0.7278539135348969
Quick ratio: 0.7243924837524724
Effective tax rate (%): 75.7396449704142
Interest coverage ratio: 1.2413793103448276
COGS to revenue (%): 47.132841991731084
SG&A to revenue (%): 23.85403559230631
Free cash flow (dilution-adjusted): -857342.6573426573
Buyback yield (%): 0
Retained earnings: -27921678.32167832
Inventory turnover: 53.51020408163265
Receivables turnover: 0.8138395143003438
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7941510147485188
FCF margin (%): -11.019234226136977
Rule of 40 score: -11.019234226136977
Financial ratios for TXP.L — quarterly report dated 2025-06-30
Total revenue: 8050364.963503649
Gross profit: 4179562.04379562
Operating income: 26277.37226277372
Net income: -518248.1751824817
Capital expenditures: 288321.16788321163
Operating cash flow: -170802.9197080292
Depreciation & amortization: 1934306.5693430656
Net tangible assets: 53951824.81751824
Owner earnings: 1127737.2262773723
Capex to operating income (%): 1097.2222222222222
Buffett classification: The Gruesome
Stock price: 0.0019178082191780826
Shares outstanding: 351364939
Book value: 53951824.81751825
P/B ratio: 0.012489856834766508
Market cap (USD): 673850.5679452056
Debt to equity: 0.8837567984414318
Current ratio: 0.7581859855926654
Quick ratio: 0.756078094302554
Interest coverage ratio: 0.025513819985825654
COGS to revenue (%): 48.08232840692719
SG&A to revenue (%): 20.645570767975336
Free cash flow (dilution-adjusted): -3510948.905109489
Buyback yield (%): 0
Retained earnings: -29662773.722627737
Inventory turnover: 51.48543689320388
Receivables turnover: 0.3722492237073039
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.019984012789768184
FCF margin (%): -43.61229485900807
Revenue growth (%): 3.469547886124561
Rule of 40 score: -40.14274697288351
Financial ratios for TXP.L — quarterly report dated 2025-09-30
Total revenue: 9174820.143884894
Gross profit: 4241726.618705036
Operating income: -1042446.0431654677
Net income: -1484892.0863309354
Capital expenditures: 6618705.035971223
Operating cash flow: 3489208.6330935257
Depreciation & amortization: 2892086.330935252
Net tangible assets: 51507913.66906475
Owner earnings: -5211510.791366907
Return on net tangible assets (%): -10.11788368065255
Buffett classification: The Gruesome
Stock price: 0.0017567567567567566
Shares outstanding: 351364939
Book value: 51507913.66906476
P/B ratio: 0.01198384261186643
Market cap (USD): 617262.7306756757
Debt to equity: 1.0364964523157718
Current ratio: 0.5869923201352356
Quick ratio: 0.5852435843254981
Interest coverage ratio: -1.019704433497537
COGS to revenue (%): 53.767740923704224
SG&A to revenue (%): 25.31169136673724
Free cash flow (dilution-adjusted): -3678417.266187051
Buyback yield (%): 0
Retained earnings: -30720863.30935252
Inventory turnover: 57.141666666666666
Receivables turnover: 0.5323287556872731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8636566830576665
FCF margin (%): -40.09252724849055
Revenue growth (%): 13.967754076727756
Rule of 40 score: -26.12477317176279
Financial ratios for TXP.L — quarterly report dated 2025-12-31
Total revenue: 8294160.583941605
Gross profit: 3478832.1167883207
Operating income: -575912.408759124
Net income: 9942335.766423358
Capital expenditures: 5432846.715328467
Operating cash flow: 7228467.153284671
Depreciation & amortization: 2473722.627737226
Net tangible assets: 68370802.91970803
Owner earnings: 6983211.678832117
Return on net tangible assets (%): 10.21373361233292
Buffett classification: The Gruesome
Stock price: 0.000945945945945946
P/E ratio: 0.04171408063621029
Shares outstanding: 351364939
Book value: 68370802.91970803
P/B ratio: 0.004861318361068824
Market cap (USD): 332372.23959459463
Debt to equity: 0.7519323568347781
Current ratio: 0.6087324811335284
Quick ratio: 0.607469582627445
Effective tax rate (%): -221.40160453043887
Interest coverage ratio: -0.5471567267683772
COGS to revenue (%): 58.05685118366629
SG&A to revenue (%): 16.412919123470914
Free cash flow (dilution-adjusted): 1967153.2846715327
Buyback yield (%): 0
Retained earnings: -21227007.29927007
Inventory turnover: 80.45121951219514
Receivables turnover: 0.4033867016933508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.44539280936171644
FCF margin (%): 23.71732817037754
Revenue growth (%): -9.59865747919055
Rule of 40 score: 14.118670691186992
Financial ratios for TXP.L — annual report dated 2025-12-31
Total revenue: 33774452.55474452
Gross profit: 16255474.452554744
Operating income: -871532.8467153284
Net income: 7947445.255474452
Capital expenditures: 20713138.686131384
Operating cash flow: 14693430.656934306
Depreciation & amortization: 9113138.686131386
Net tangible assets: 68370802.91970803
Owner earnings: -3652554.744525548
Return on net tangible assets (%): -5.34227270786181
Buffett classification: The Gruesome
Stock price: 0.000945945945945946
P/E ratio: 0.04182126820762258
Shares outstanding: 351364939
Book value: 68370802.91970803
P/B ratio: 0.004861318361068824
Market cap (USD): 332372.23959459463
Debt to equity: 0.7519323568347781
Current ratio: 0.6087324811335284
Quick ratio: 0.607469582627445
Interest coverage ratio: -0.23476209201730242
COGS to revenue (%): 51.87050204231593
SG&A to revenue (%): 21.663677033130906
Free cash flow (dilution-adjusted): -6170802.919708029
Buyback yield (%): 0
Retained earnings: -21227007.29927007
Inventory turnover: 292.6951219512195
Receivables turnover: 1.6426213213106604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6740164947755254
FCF margin (%): -18.270623068444603
Revenue growth (%): -16.05258346812323
Rule of 40 score: -34.32320653656784
Financial ratios for UGP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.36
Shares outstanding: 1068821226
Market cap (USD): 2522418093.3599997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGP — annual report dated 2022-12-31
Total revenue: 27203543181.81818
Gross profit: 1393646022.7272727
Operating income: 599006439.3939394
Net income: 348497916.6666666
Capital expenditures: 228567424.24242422
Operating cash flow: 379676893.93939394
Depreciation & amortization: 194568750
Net tangible assets: 1854240909.090909
Owner earnings: 314499242.4242424
Return on net tangible assets (%): 16.961077758684226
Capex to operating income (%): 38.15775744809745
Buffett classification: The Good
Stock price: 2.25
P/E ratio: 6.900608708086491
Shares outstanding: 1068821226
Book value: 2305865151.515151
P/B ratio: 1.042926450802992
Market cap (USD): 2404847758.5
Debt to equity: 1.0905673016963988
Current ratio: 1.4541934469098683
Quick ratio: 1.0698924790142008
Effective tax rate (%): 18.168295894346247
Interest coverage ratio: 1.9849986945563
COGS to revenue (%): 94.87696873376872
SG&A to revenue (%): 2.559594440084774
Free cash flow (dilution-adjusted): 151109469.6969697
Buyback yield (%): 0
Inventory turnover: 27.776997861634218
Receivables turnover: 19.429270264965545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.359185910762061
FCF margin (%): 0.5554771622468854
Rule of 40 score: 0.5554771622468854
Financial ratios for UGP — annual report dated 2023-12-31
Total revenue: 25989422886.59794
Gross profit: 1921284948.4536083
Operating income: 897435051.5463918
Net income: 519124329.89690727
Capital expenditures: 265428865.97938147
Operating cash flow: 793777731.958763
Depreciation & amortization: 238101855.6701031
Net tangible assets: 2258263505.1546392
Owner earnings: 491797319.58762896
Return on net tangible assets (%): 21.777676452064533
Capex to operating income (%): 29.576387229584427
Buffett classification: The Good
Stock price: 5.15
P/E ratio: 10.603296738168915
Shares outstanding: 1068821226
Book value: 2892747628.865979
P/B ratio: 1.902837723890161
Market cap (USD): 5504429313.900001
Debt to equity: 0.9476289299667724
Current ratio: 1.6606823645029973
Quick ratio: 1.2785308332631322
Effective tax rate (%): 29.646058130128438
Interest coverage ratio: 2.6781886157170742
COGS to revenue (%): 92.60743512144565
SG&A to revenue (%): 3.3886783172799215
Free cash flow (dilution-adjusted): 528348865.9793815
Buyback yield (%): 0
Inventory turnover: 27.20082625119686
Receivables turnover: 15.679805371865871
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.107279627697345
FCF margin (%): 2.0329380466999023
Revenue growth (%): -4.463096175029559
Rule of 40 score: -2.4301581283296567
Financial ratios for UGP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.77
Shares outstanding: 1068821226
Market cap (USD): 4029456022.02
Buyback yield (%): 0
Retained earnings: 229928176.79558012
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 1068821226
Market cap (USD): 2736182338.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGP — annual report dated 2024-12-31
Total revenue: 21601765857.60518
Gross profit: 1567478964.4012945
Operating income: 791290453.0744337
Net income: 408721682.84789646
Capital expenditures: 289186893.2038835
Operating cash flow: 604462135.9223301
Depreciation & amortization: 196235113.26860842
Net tangible assets: 2144075728.15534
Owner earnings: 315769902.9126214
Return on net tangible assets (%): 14.727553638429306
Capex to operating income (%): 36.546238120312665
Buffett classification: The Good
Stock price: 2.56
P/E ratio: 6.69448784682719
Shares outstanding: 1068821226
Book value: 2560427831.7152104
P/B ratio: 1.068642632558424
Market cap (USD): 2736182338.56
Debt to equity: 0.9698054355297114
Current ratio: 1.5293446680379037
Quick ratio: 1.1560480924743555
Effective tax rate (%): 37.03379544446652
Interest coverage ratio: 3.5707348952001254
COGS to revenue (%): 92.74374616068971
SG&A to revenue (%): 3.2746626184139793
Free cash flow (dilution-adjusted): 315275242.7184466
Buyback yield (%): 0.8808306502982585
Inventory turnover: 31.608243751206256
Receivables turnover: 18.539100461634305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.82503481092107
FCF margin (%): 1.4594882881181213
Revenue growth (%): -16.882471950754084
Rule of 40 score: -15.422983662635962
Financial ratios for UGP — quarterly report dated 2025-03-31
Total revenue: 6019464756.944445
Gross profit: 371810937.5
Operating income: 157831423.6111111
Net income: 63052777.77777778
Capital expenditures: 63788888.88888889
Operating cash flow: 524131.94444444444
Depreciation & amortization: 52790104.16666667
Net tangible assets: 2278083333.3333335
Owner earnings: 52053993.05555556
Return on net tangible assets (%): 2.2849907329504577
Capex to operating income (%): 40.415835724869076
Buffett classification: The Good
Stock price: 3.08
P/E ratio: 13.052435959610555
Shares outstanding: 1068821226
Book value: 2758751041.6666665
P/B ratio: 1.1932825131227487
Market cap (USD): 3291969376.08
Debt to equity: 0.9465883376422226
Current ratio: 1.7560631502644313
Quick ratio: 1.2578489600829754
Effective tax rate (%): 40.564239108555235
Interest coverage ratio: 2.4474006552540115
COGS to revenue (%): 89.95017812151477
SG&A to revenue (%): 3.230050821529011
Free cash flow (dilution-adjusted): -65776388.88888889
Buyback yield (%): 0.5103644580883968
Inventory turnover: 7.542650653459859
Receivables turnover: 4.848843627698114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0864040984704912
FCF margin (%): -1.092728200011554
Rule of 40 score: -1.092728200011554
Financial ratios for UGP — quarterly report dated 2025-06-30
Total revenue: 6214423905.1094885
Gross profit: 391917335.76642334
Operating income: 257272992.7007299
Net income: 209951094.89051095
Capital expenditures: 87352189.7810219
Operating cash flow: 167500547.44525546
Depreciation & amortization: 71874817.51824817
Net tangible assets: 2265239416.058394
Owner earnings: 194473722.62773722
Return on net tangible assets (%): 8.585128849917735
Capex to operating income (%): 33.95311294203096
Buffett classification: The Good
Stock price: 3.28
P/E ratio: 12.841332934275314
Shares outstanding: 1068821226
Book value: 3356892153.284672
P/B ratio: 1.044339067565721
Market cap (USD): 3505733621.2799997
Debt to equity: 1.0294754734091298
Current ratio: 1.8165394561347001
Quick ratio: 1.381334821015326
Effective tax rate (%): 23.20090068009735
Interest coverage ratio: 2.08626167353033
COGS to revenue (%): 93.69342449516215
SG&A to revenue (%): 3.488197034430407
Free cash flow (dilution-adjusted): 80148357.66423357
Buyback yield (%): 0.768084806438847
Retained earnings: 259352737.22627735
Inventory turnover: 7.900603056260902
Receivables turnover: 4.517204019384623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.880861139286165
FCF margin (%): 1.289715006379525
Revenue growth (%): 3.2388120212868814
Rule of 40 score: 4.5285270276664065
Financial ratios for UGP — quarterly report dated 2025-09-30
Total revenue: 6961250939.849624
Gross profit: 465709774.4360902
Operating income: 268440789.4736842
Net income: 145188909.7744361
Capital expenditures: 89178947.36842105
Operating cash flow: 404131578.9473684
Depreciation & amortization: 85051503.75939849
Net tangible assets: 2471499624.06015
Owner earnings: 141061466.16541353
Return on net tangible assets (%): 5.707525293233888
Capex to operating income (%): 33.221086684802586
Buffett classification: The Good
Stock price: 4.1
P/E ratio: 10.478820320626111
Shares outstanding: 1068821226
Book value: 3508756766.9172926
P/B ratio: 1.2489229997125346
Market cap (USD): 4382167026.599999
Debt to equity: 0.9907176384583664
Current ratio: 1.8290952511518945
Quick ratio: 1.3998999089438509
Effective tax rate (%): 24.945029493651138
Interest coverage ratio: 1.8439724095900174
COGS to revenue (%): 93.30997002607478
SG&A to revenue (%): 3.1673127196723105
Free cash flow (dilution-adjusted): 314952631.57894737
Buyback yield (%): 0.09697540131069673
Retained earnings: 339187593.9849624
Inventory turnover: 9.036490064805095
Receivables turnover: 5.174591084980493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8960945424230173
FCF margin (%): 4.524368311103449
Revenue growth (%): 12.0176390626667
Rule of 40 score: 16.542007373770147
Financial ratios for UGP — quarterly report dated 2025-12-31
Total revenue: 6925434306.569343
Gross profit: 472979379.5620438
Operating income: 206439781.0218978
Net income: 59024635.03649635
Capital expenditures: 122304744.52554743
Operating cash flow: 434598540.14598536
Depreciation & amortization: 123659671.5328467
Net tangible assets: 2253612043.7956204
Owner earnings: 60379562.04379563
Return on net tangible assets (%): 2.6792349734740517
Capex to operating income (%): 59.24475598652865
Buffett classification: The Good
Stock price: 3.77
P/E ratio: 8.44364827106389
Shares outstanding: 1068821226
Book value: 3235514051.0948906
P/B ratio: 1.245383564523987
Market cap (USD): 4029456022.02
Debt to equity: 1.2313668497830614
Current ratio: 1.6186303022854742
Quick ratio: 1.2603927091169125
Effective tax rate (%): 31.785076075342815
Interest coverage ratio: 1.75120122351426
COGS to revenue (%): 93.17040118172251
SG&A to revenue (%): 3.3898503822522392
Free cash flow (dilution-adjusted): 312293795.6204379
Buyback yield (%): 5.43443335758273e-05
Inventory turnover: 8.331311655251776
Receivables turnover: 5.2407914563982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0166406011468827
FCF margin (%): 4.509374889661457
Revenue growth (%): -0.5145143249361841
Rule of 40 score: 3.994860564725273
Financial ratios for UGP — annual report dated 2025-12-31
Total revenue: 25979843065.693428
Gross profit: 1707817700.7299268
Operating income: 885571715.3284671
Net income: 463851824.81751823
Capital expenditures: 365920255.47445256
Operating cash flow: 994982116.7883211
Depreciation & amortization: 289445802.919708
Net tangible assets: 2253612043.7956204
Owner earnings: 387377372.2627737
Return on net tangible assets (%): 17.18917740652192
Capex to operating income (%): 41.320228406203015
Buffett classification: The Good
Stock price: 3.77
P/E ratio: 8.686946577401542
Shares outstanding: 1068821226
Book value: 3235514051.0948906
P/B ratio: 1.245383564523987
Market cap (USD): 4029456022.02
Debt to equity: 1.2313668497830614
Current ratio: 1.6186303022854742
Quick ratio: 1.2603927091169125
Effective tax rate (%): 27.904364978282537
Interest coverage ratio: 2.015759527741687
COGS to revenue (%): 93.42637406849808
SG&A to revenue (%): 3.3485442180960896
Free cash flow (dilution-adjusted): 629061861.3138685
Buyback yield (%): 1.2089531021167836
Inventory turnover: 31.339669956203387
Receivables turnover: 19.660130116041678
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.940585280914307
FCF margin (%): 2.4213458862057147
Revenue growth (%): 20.26721906416225
Rule of 40 score: 22.688564950367965
Financial ratios for VRY.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7086614173228345
Shares outstanding: 32729703
Market cap (USD): 55923980.71653543
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRY.V — annual report dated 2022-12-31
Total revenue: 1700000
Gross profit: 545000
Operating income: -4920000
Net income: -6818000
Capital expenditures: 4390000
Operating cash flow: -4355000
Depreciation & amortization: 286000
Net tangible assets: 2983000
Owner earnings: -10922000
Return on net tangible assets (%): -366.1414683204828
Buffett classification: The Gruesome
Stock price: 2.235294117647059
Shares outstanding: 32729703
Book value: 2983000
P/B ratio: 24.525817159985014
Market cap (USD): 73160512.58823529
Debt to equity: 2.2537713711029164
Current ratio: 0.052825552825552825
Quick ratio: 0.052825552825552825
Interest coverage ratio: -11.156462585034014
COGS to revenue (%): 57.94117647058824
SG&A to revenue (%): 270.5882352941177
Free cash flow (dilution-adjusted): -9859000
Buyback yield (%): 0
Retained earnings: -82157000
Receivables turnover: 85
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.29135597901132
FCF margin (%): -579.9411764705883
Rule of 40 score: -579.9411764705883
Financial ratios for VRY.V — annual report dated 2023-12-31
Total revenue: 1955000
Gross profit: 223000
Operating income: -5903000
Net income: -6166000
Capital expenditures: 2169000
Operating cash flow: -4055000
Depreciation & amortization: 451000
Net tangible assets: 697000
Owner earnings: -7884000
Return on net tangible assets (%): -1131.1334289813485
Buffett classification: The Gruesome
Stock price: 1.5909090909090908
Shares outstanding: 32729703
Book value: 697000
P/B ratio: 74.7058565931916
Market cap (USD): 52069982.04545454
Debt to equity: 10.070301291248207
Current ratio: 0.08562733434776594
Quick ratio: 0.08562733434776594
Interest coverage ratio: -8.34936350777935
COGS to revenue (%): 78.82352941176471
SG&A to revenue (%): 293.5549872122762
Free cash flow (dilution-adjusted): -7344000
Buyback yield (%): 0
Retained earnings: -89043000
Receivables turnover: 21.72222222222222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -98.59696008017372
FCF margin (%): -375.6521739130435
Revenue growth (%): 15
Rule of 40 score: -360.6521739130435
Financial ratios for VRY.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9259259259259258
Shares outstanding: 32729703
Market cap (USD): 30305280.555555552
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRY.V — annual report dated 2024-12-31
Total revenue: 1250000
Gross profit: -213000
Operating income: -6784000
Net income: -7352000
Capital expenditures: 2564000
Operating cash flow: -4711000
Depreciation & amortization: 595000
Net tangible assets: -4899000
Owner earnings: -9321000
Buffett classification: The Gruesome
Stock price: 0.6013986013986015
Shares outstanding: 32729703
Book value: -4899000
Market cap (USD): 19683597.60839161
Debt to equity: -2.0869565217391304
Current ratio: 0.043629075772758805
Quick ratio: 0.043629075772758805
Interest coverage ratio: -6.167272727272727
COGS to revenue (%): 107.28
SG&A to revenue (%): 482.64
Free cash flow (dilution-adjusted): -8023000
Buyback yield (%): 0
Retained earnings: -95551000
Receivables turnover: 21.551724137931036
Capitalized R&D asset: 0
FCF margin (%): -641.84
Revenue growth (%): -36.0613810741688
Rule of 40 score: -677.9013810741689
Financial ratios for VRY.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6013986013986015
Shares outstanding: 32729703
Market cap (USD): 19683597.60839161
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRY.V — quarterly report dated 2025-03-31
Total revenue: 220000
Gross profit: -113000
Operating income: -1507000
Net income: -2848000
Capital expenditures: 26000
Operating cash flow: -1289000
Depreciation & amortization: 121000
Net tangible assets: -6664000
Owner earnings: -2753000
Buffett classification: The Gruesome
Stock price: 0.8741258741258742
Shares outstanding: 32729703
Book value: -6664000
Market cap (USD): 28609880.244755246
Debt to equity: -1.6494597839135654
Current ratio: 0.02638898794665145
Quick ratio: 0.02638898794665145
Interest coverage ratio: -4.186111111111111
COGS to revenue (%): 142.27272727272725
SG&A to revenue (%): 632.7272727272727
Free cash flow (dilution-adjusted): -1476000
Buyback yield (%): 0
Retained earnings: -100683000
Receivables turnover: 3.1884057971014492
Capitalized R&D asset: 0
FCF margin (%): -670.9090909090909
Rule of 40 score: -670.9090909090909
Financial ratios for VRY.V — quarterly report dated 2025-06-30
Total revenue: 162000
Gross profit: -102000
Operating income: -1319000
Net income: 34000
Capital expenditures: 760000
Operating cash flow: 75000
Depreciation & amortization: 80000
Net tangible assets: -6039000
Owner earnings: -646000
Buffett classification: The Gruesome
Stock price: 0.36496350364963503
P/E ratio: 87.83196382567625
Shares outstanding: 32729703
Book value: -6039000
Market cap (USD): 11945147.080291972
Debt to equity: -1.9814538830932273
Current ratio: 0.028176968936303733
Quick ratio: 0.028176968936303733
Effective tax rate (%): 0
Interest coverage ratio: -3.1630695443645083
COGS to revenue (%): 153.0864197530864
SG&A to revenue (%): 747.5308641975308
Free cash flow (dilution-adjusted): -864000
Buyback yield (%): 0
Retained earnings: -100650000
Receivables turnover: 1.8620689655172413
Capitalized R&D asset: 0
FCF margin (%): -533.3333333333333
Revenue growth (%): -26.36363636363636
Rule of 40 score: -559.6969696969696
Financial ratios for VRY.V — quarterly report dated 2025-09-30
Total revenue: 146000
Gross profit: -145000
Operating income: -1461000
Net income: -1683000
Capital expenditures: 1190000
Operating cash flow: -479000
Depreciation & amortization: 165000
Net tangible assets: -5046000
Owner earnings: -2708000
Buffett classification: The Gruesome
Stock price: 0.38848920863309355
Shares outstanding: 32729703
Book value: -5046000
Market cap (USD): 12715136.417266188
Debt to equity: -2.370986920332937
Current ratio: 0.10469276639875551
Quick ratio: 0.10469276639875551
Interest coverage ratio: -3.1284796573875804
COGS to revenue (%): 199.31506849315068
SG&A to revenue (%): 865.7534246575343
Free cash flow (dilution-adjusted): -1867000
Buyback yield (%): 0
Retained earnings: -102334000
Receivables turnover: 1.3518518518518519
Capitalized R&D asset: 0
FCF margin (%): -1278.7671232876712
Revenue growth (%): -9.876543209876543
Rule of 40 score: -1288.6436664975477
Financial ratios for VRY.V — annual report dated 2025-12-31
Total revenue: 659000
Gross profit: -762000
Operating income: -7981000
Net income: -9215000
Capital expenditures: 2751000
Operating cash flow: -3648000
Depreciation & amortization: 781000
Net tangible assets: -9768000
Owner earnings: -11185000
Buffett classification: The Gruesome
Stock price: 0.49635036496350365
Shares outstanding: 32729703
Book value: -9768000
Market cap (USD): 16245400.02919708
Debt to equity: -1.3398853398853399
Current ratio: 0.02914808955366988
Quick ratio: 0.02914808955366988
Interest coverage ratio: -4.756257449344457
COGS to revenue (%): 206.22154779969654
SG&A to revenue (%): 842.9438543247345
Free cash flow (dilution-adjusted): -7099000
Buyback yield (%): 0
Retained earnings: -107051000
Receivables turnover: 4.544827586206897
Capitalized R&D asset: 0
FCF margin (%): -1077.2382397572078
Revenue growth (%): -47.28
Rule of 40 score: -1124.5182397572078
Financial ratios for VRY.V — quarterly report dated 2025-12-31
Total revenue: 167000
Gross profit: -403000
Operating income: -3635000
Net income: -4716000
Capital expenditures: 775000
Operating cash flow: -1955000
Depreciation & amortization: 415000
Net tangible assets: -9768000
Owner earnings: -5076000
Buffett classification: The Gruesome
Stock price: 0.49635036496350365
Shares outstanding: 32729703
Book value: -9768000
Market cap (USD): 16245400.02919708
Debt to equity: -1.3398853398853399
Current ratio: 0.02914808955366988
Quick ratio: 0.02914808955366988
Interest coverage ratio: -8.37557603686636
COGS to revenue (%): 304.19161676646706
SG&A to revenue (%): 1010.179640718563
Free cash flow (dilution-adjusted): -2892000
Buyback yield (%): 0
Retained earnings: -107051000
Receivables turnover: 1.1517241379310346
Capitalized R&D asset: 0
FCF margin (%): -1731.736526946108
Revenue growth (%): 14.383561643835616
Rule of 40 score: -1717.3529653022722
Financial ratios for VSME — annual report dated 2023-12-31
Total revenue: 6053865.909090909
Gross profit: 1242203.7878787878
Operating income: -4859290.151515151
Net income: -4995789.393939394
Capital expenditures: 2128.7878787878785
Operating cash flow: -5490072.727272727
Depreciation & amortization: 23749.242424242424
Net tangible assets: 3148250
Owner earnings: -4974168.939393939
Return on net tangible assets (%): -157.99790167216517
Buffett classification: The Gruesome
Stock price: 52.92
Shares outstanding: 2765070
Book value: 3176532.575757575
P/B ratio: 46.065167257131684
Market cap (USD): 146327504.4
Debt to equity: 0.848425348489622
Current ratio: 1.7585975660411632
Quick ratio: 1.7585975660411632
Interest coverage ratio: -22.06147311217734
COGS to revenue (%): 79.48081760427816
SG&A to revenue (%): 100.78673745038702
Free cash flow (dilution-adjusted): -6144891.666666666
Buyback yield (%): 0
Retained earnings: -16066781.818181818
Receivables turnover: 0.9410692839934081
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -145.74097750605014
FCF margin (%): -101.50359718802271
Revenue growth (%): -10.146075638643518
Rule of 40 score: -111.64967282666623
Financial ratios for VSME — annual report dated 2024-12-31
Total revenue: 6064785.294117646
Gross profit: 1244987.5
Operating income: -5077008.0882352935
Net income: -5362442.647058823
Capital expenditures: 3594.1176470588234
Operating cash flow: -1093667.6470588234
Depreciation & amortization: 22007.35294117647
Net tangible assets: -562479.4117647058
Owner earnings: -5344029.411764706
Buffett classification: The Gruesome
Stock price: 26
Shares outstanding: 2765070
Book value: 941116.176470588
P/B ratio: 76.38995248133087
Market cap (USD): 71891820
Debt to equity: 2.5048690619242797
Current ratio: 0.8362089511898473
Quick ratio: 0.8362089511898473
Interest coverage ratio: -16.84557338173727
COGS to revenue (%): 79.47186191063453
SG&A to revenue (%): 104.24104534033745
Free cash flow (dilution-adjusted): -1793176.4705882352
Buyback yield (%): 0
Retained earnings: -20956672.05882353
Receivables turnover: 2.0675592717213083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -465.0063844058866
FCF margin (%): -29.567023128213165
Revenue growth (%): 0.18037044742500496
Rule of 40 score: -29.38665268078816
Financial ratios for VSME — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -562479.4117647058
Buffett classification: The Gruesome
Stock price: 26
Shares outstanding: 2765070
Book value: 941116.176470588
P/B ratio: 76.38995248133087
Market cap (USD): 71891820
Debt to equity: 2.5048690619242797
Current ratio: 0.8362089511898473
Quick ratio: 0.8362089511898473
Buyback yield (%): 0
Retained earnings: -20956672.05882353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VSME — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.8
Shares outstanding: 2765070
Market cap (USD): 57513456
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEB.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.32954545454545
Shares outstanding: 3502882
Market cap (USD): 113246582.8409091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEB.BR — annual report dated 2022-12-31
Total revenue: 25028461.70212766
Gross profit: 21217551.063829787
Operating income: 17231851.063829787
Net income: 12919837.234042553
Capital expenditures: 0
Operating cash flow: 16326106.382978724
Net tangible assets: 180060314.89361703
Owner earnings: 12919837.234042553
Return on net tangible assets (%): 7.175283038728346
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 27.75531914893617
P/E ratio: 7.525141848914999
Shares outstanding: 3502882
Book value: 180060314.89361703
P/B ratio: 0.5399502267254467
Market cap (USD): 97223607.85106383
Debt to equity: 0.8004810633902484
Current ratio: 0.5199083308853775
Quick ratio: 0.5199083308853775
Effective tax rate (%): 0.02038342741733989
Interest coverage ratio: 7.717571476421011
COGS to revenue (%): 15.226307887607446
SG&A to revenue (%): 11.129397621108291
Free cash flow (dilution-adjusted): 16326106.382978724
Buyback yield (%): 0
Retained earnings: 49304718.08510639
Receivables turnover: 25.705697443825905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.870589248643194
FCF margin (%): 65.23016307306992
Rule of 40 score: 65.23016307306992
Financial ratios for WEB.BR — annual report dated 2023-12-31
Total revenue: 28982867.777777776
Gross profit: 24509812.22222222
Operating income: 20189682.22222222
Net income: 9631254.444444444
Capital expenditures: 0
Operating cash flow: 17808620
Net tangible assets: 186119528.8888889
Owner earnings: 9631254.444444444
Return on net tangible assets (%): 5.174768334060305
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.22222222222222
P/E ratio: 11.355505230713572
Shares outstanding: 3502882
Book value: 186119528.88888887
P/B ratio: 0.5876210888515275
Market cap (USD): 109367760.22222222
Debt to equity: 0.9010850768922835
Current ratio: 0.5041415702448248
Quick ratio: 0.5041415702448248
Effective tax rate (%): 0.01148904877943276
Interest coverage ratio: 3.0875438050366615
COGS to revenue (%): 15.433447062078551
SG&A to revenue (%): 9.435279025566867
Free cash flow (dilution-adjusted): 17808620
Buyback yield (%): 0
Retained earnings: 49838503.333333336
Receivables turnover: 24.757621977262673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.223229797094616
FCF margin (%): 61.44533431455158
Revenue growth (%): 15.799636920210528
Rule of 40 score: 77.2449712347621
Financial ratios for WEB.BR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.55555555555555
Shares outstanding: 3502882
Market cap (USD): 128049797.55555554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEB.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 188879746.875
Buffett classification: The Gruesome
Stock price: 32.864583333333336
Shares outstanding: 3502882
Book value: 188879746.87500003
P/B ratio: 0.6094923320286948
Market cap (USD): 115120757.39583334
Debt to equity: 0.8522734623308633
Current ratio: 0.6655249832305565
Quick ratio: 0.6655249832305565
Buyback yield (%): 0
Retained earnings: 50442680.208333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEB.BR — annual report dated 2024-12-31
Total revenue: 30079597.916666668
Gross profit: 25636616.666666668
Operating income: 21044510.416666668
Net income: 11082628.125
Capital expenditures: 0
Operating cash flow: 18659334.375
Net tangible assets: 188879746.875
Owner earnings: 11082628.125
Return on net tangible assets (%): 5.867557696556236
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.864583333333336
P/E ratio: 10.387496187492381
Shares outstanding: 3502882
Book value: 188879746.87500003
P/B ratio: 0.6094923320286948
Market cap (USD): 115120757.39583334
Debt to equity: 0.8522734623308633
Current ratio: 0.6655249832305565
Quick ratio: 0.6655249832305565
Effective tax rate (%): 0.006597728858719786
Interest coverage ratio: 2.7132741489730035
COGS to revenue (%): 14.770746810874785
SG&A to revenue (%): 9.078554560133401
Free cash flow (dilution-adjusted): 18659334.375
Buyback yield (%): 0
Retained earnings: 50442680.208333336
Receivables turnover: 29.528582267970393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.073141221343869
FCF margin (%): 62.03319082487181
Revenue growth (%): 3.7840635623014327
Rule of 40 score: 65.81725438717324
Financial ratios for ZYDUSLIFE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.458657523407623
Shares outstanding: 997503832
Market cap (USD): 4447527965.174733
Buyback yield (%): 0
Retained earnings: 2043492021.6273243
Capitalized R&D asset: 15112752.208888303
Rule of 40 score: 0
Financial ratios for ZYDUSLIFE.NS — annual report dated 2023-03-31
Total revenue: 2055761266.7478685
Gross profit: 1256869671.132765
Operating income: 347478684.5310597
Net income: 254799025.57856274
Capital expenditures: 120767356.8818514
Operating cash flow: 327503045.0669915
Depreciation & amortization: 88026796.58952497
Net tangible assets: 1415456760.048721
Owner earnings: 222058465.28623632
Return on net tangible assets (%): 15.688113657289884
Capex to operating income (%): 34.755328098710045
Buffett classification: The Good
Stock price: 5.850182704019489
P/E ratio: 22.902676538534347
Shares outstanding: 997503832
Book value: 2398087697.9293547
P/B ratio: 2.4334304663663193
Market cap (USD): 5835579665.159562
Debt to equity: 0.060690867164762824
Current ratio: 1.8110546585423184
Quick ratio: 1.193899506391596
Effective tax rate (%): 22.697609761748467
Interest coverage ratio: 22.731474103585654
COGS to revenue (%): 38.86110749031272
R&D to revenue (%): 0.804607235540177
SG&A to revenue (%): 12.679970138288166
Free cash flow (dilution-adjusted): 201936662.60657737
Buyback yield (%): 1.8017074414960106
Retained earnings: 2093763702.8014617
Inventory turnover: 1.921571499721677
Receivables turnover: 3.821273320050715
Capitalized R&D asset: 26666347.877640914
ROCI (R&D-adjusted, %): 14.194312474618966
FCF margin (%): 9.822962708409865
Rule of 40 score: 9.822962708409865
Financial ratios for ZYDUSLIFE.NS — annual report dated 2024-03-31
Total revenue: 2281028900.3477635
Gross profit: 1501510972.5386736
Operating income: 544333852.9799737
Net income: 476412039.8129272
Capital expenditures: 105876004.31706439
Operating cash flow: 383295359.15577406
Depreciation & amortization: 91629691.8095695
Net tangible assets: 1433325338.7696366
Owner earnings: 462165727.3054323
Return on net tangible assets (%): 32.244300355574154
Capex to operating income (%): 19.450563976031017
Buffett classification: The Great
Stock price: 11.917706333973129
P/E ratio: 24.953100978423876
Shares outstanding: 997503832
Book value: 2650389734.9802136
P/B ratio: 4.485362126139391
Market cap (USD): 11887957736.788868
Debt to equity: 0.036386505954320046
Current ratio: 2.153054156760703
Quick ratio: 1.5087328478631197
Effective tax rate (%): 20.326893884256275
Interest coverage ratio: 103.16363636363637
COGS to revenue (%): 34.17396104408169
R&D to revenue (%): 0.8190731540625082
SG&A to revenue (%): 11.437583786767606
Free cash flow (dilution-adjusted): 274577287.4445377
Buyback yield (%): 0.7313357106949738
Retained earnings: 2442619019.0670342
Inventory turnover: 1.888608036259043
Receivables turnover: 3.6438259070533694
Capitalized R&D asset: 34752842.199538365
ROCI (R&D-adjusted, %): 18.800346651099304
Rosenberg metric: 14.790169989267374
FCF margin (%): 12.037431327708118
Revenue growth (%): 10.957869342302539
Rule of 40 score: 22.995300670010657
Financial ratios for ZYDUSLIFE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1627173913.0434783
Buffett classification: The Gruesome
Stock price: 12.618848542761587
Shares outstanding: 997503832
Book value: 2885164835.1648355
P/B ratio: 4.362783582905119
Market cap (USD): 12587349776.832298
Debt to equity: 0.007886696529853526
Current ratio: 2.271723287364054
Quick ratio: 1.577157379377359
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZYDUSLIFE.NS — quarterly report dated 2024-12-31
Total revenue: 597214127.52069
Gross profit: 412647161.6738547
Operating income: 113766173.21366125
Net income: 119617671.05723277
Capital expenditures: 0
Depreciation & amortization: 26693087.77246765
Owner earnings: 146310758.8297004
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.1981582935074
P/E ratio: 23.345643060906255
Shares outstanding: 997503832
Market cap (USD): 11170205809.116213
Effective tax rate (%): 15.159192635757115
Interest coverage ratio: 30.499999999999996
COGS to revenue (%): 30.904655020981753
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZYDUSLIFE.NS — annual report dated 2025-03-31
Total revenue: 2638975917.6993217
Gross profit: 1859644610.7084403
Operating income: 699006312.8361
Net income: 546247369.6516249
Capital expenditures: 191992050.5026888
Operating cash flow: 792740238.4849193
Depreciation & amortization: 107061024.08230066
Net tangible assets: 1810544774.3745615
Owner earnings: 461316343.2312368
Return on net tangible assets (%): 25.479421981739993
Capex to operating income (%): 27.46642583580018
Buffett classification: The Good
Stock price: 10.227097677675342
P/E ratio: 18.675731345352958
Shares outstanding: 997503832
Book value: 3081412204.81646
P/B ratio: 3.3106797940806807
Market cap (USD): 10201569123.719454
Debt to equity: 0.1219042126987981
Current ratio: 1.8852968501150238
Quick ratio: 1.4490908688727657
Effective tax rate (%): 23.427414671379026
Interest coverage ratio: 63.949732620320844
COGS to revenue (%): 29.531580859226185
R&D to revenue (%): 2.3620303183336433
SG&A to revenue (%): 12.700121379652519
Free cash flow (dilution-adjusted): 594739303.2499415
Buyback yield (%): 0
Retained earnings: 2871358428.8052373
Inventory turnover: 1.69026369168357
Receivables turnover: 5.526292596944771
Capitalized R&D asset: 80309684.44645214
ROCI (R&D-adjusted, %): 21.61166186246225
Rosenberg metric: 19.168654741320182
FCF margin (%): 22.536746139329665
Revenue growth (%): 15.692349066554392
Rule of 40 score: 38.22909520588406
Financial ratios for ZYDUSLIFE.NS — quarterly report dated 2025-03-31
Total revenue: 735351882.1603928
Gross profit: 536953472.059855
Operating income: 225274725.27472526
Net income: 145393967.73439327
Capital expenditures: 0
Depreciation & amortization: 27811550.15197568
Net tangible assets: 1810544774.3745615
Owner earnings: 173205517.88636896
Return on net tangible assets (%): 9.566486304996321
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.227097677675342
P/E ratio: 17.541252368797984
Shares outstanding: 997503832
Book value: 3081412204.81646
P/B ratio: 3.3106797940806807
Market cap (USD): 10201569123.719454
Debt to equity: 0.1219042126987981
Current ratio: 1.8852968501150238
Quick ratio: 1.4490908688727657
Effective tax rate (%): 25.311004784688997
Interest coverage ratio: 25.156657963446474
COGS to revenue (%): 26.980064226892626
Buyback yield (%): 0
Retained earnings: 2871358428.8052373
Inventory turnover: 0.43029918864097366
Receivables turnover: 1.5399040344692518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.843015472246192
Revenue growth (%): 23.130356144315613
Rule of 40 score: 23.130356144315613
Financial ratios for ZYDUSLIFE.NS — quarterly report dated 2025-06-30
Total revenue: 756728293.9386848
Gross profit: 547332085.186052
Operating income: 209840861.22162417
Net income: 177978001.40416571
Capital expenditures: 0
Depreciation & amortization: 27860987.596536394
Owner earnings: 205838989.0007021
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.452609407910135
P/E ratio: 25.788462605447034
Shares outstanding: 997503832
Market cap (USD): 11424021770.78961
Effective tax rate (%): 22.597105071331878
Interest coverage ratio: 21.172373081463988
COGS to revenue (%): 27.671254059069124
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.9069636315460605
Rule of 40 score: 2.9069636315460605
Financial ratios for ZYDUSLIFE.NS — quarterly report dated 2025-12-31
Total revenue: 755308009.3572463
Gross profit: 550751921.5773644
Operating income: 143967918.01269913
Net income: 116085551.96613568
Capital expenditures: 0
Depreciation & amortization: 40057925.81040437
Owner earnings: 156143477.77654004
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.185473989083214
P/E ratio: 18.172956835301914
Shares outstanding: 997503832
Market cap (USD): 10160049334.846832
Effective tax rate (%): 28.690704891384662
Interest coverage ratio: 9.94919168591224
COGS to revenue (%): 27.082473010441866
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.18768752177166806
Rule of 40 score: -0.18768752177166806
Financial ratios for 0325.HK — annual report dated 2022-12-31
Total revenue: 46777873.56321839
Gross profit: 17732614.942528736
Operating income: -36389080.45977011
Net income: -60328448.27586207
Capital expenditures: 2423419.540229885
Operating cash flow: -24243821.83908046
Depreciation & amortization: 5585775.862068965
Net tangible assets: -196914367.81609195
Owner earnings: -57166091.95402299
Buffett classification: The Gruesome
Shares outstanding: 246349645
Book value: -197861350.57471263
Debt to equity: -0.02558464616244831
Current ratio: 0.9572374723607422
Quick ratio: 0.9220203254628694
Interest coverage ratio: -161.93606138107418
COGS to revenue (%): 62.09187465829581
R&D to revenue (%): 30.23705824175149
SG&A to revenue (%): 49.2066319792121
Free cash flow (dilution-adjusted): -28399856.32183908
Retained earnings: -282476867.81609195
Inventory turnover: 3.302754541889949
Receivables turnover: 21.420751365221395
Capitalized R&D asset: 14144252.873563219
ROCI (R&D-adjusted, %): -61.26416741217673
FCF margin (%): -60.71215760472273
Rule of 40 score: -60.71215760472273
Financial ratios for 0325.HK — annual report dated 2023-12-31
Total revenue: 123303234.88045007
Gross profit: 58357524.61322081
Operating income: 11623206.751054851
Net income: -28987341.7721519
Capital expenditures: 3412939.521800281
Operating cash flow: 40069198.31223629
Depreciation & amortization: 6285794.655414908
Net tangible assets: -226727144.86638537
Owner earnings: -26114486.63853727
Capex to operating income (%): 29.363149042242952
Buffett classification: The Good
Shares outstanding: 246349645
Book value: -226201687.76371306
Debt to equity: -0.039802424183638066
Current ratio: 0.9334604844237634
Quick ratio: 0.82907527682042
Interest coverage ratio: 137.73499999999999
COGS to revenue (%): 52.67153804212683
R&D to revenue (%): 10.797138314059994
SG&A to revenue (%): 27.20586390110028
Free cash flow (dilution-adjusted): 33097046.41350211
Retained earnings: -305504781.997187
Inventory turnover: 6.052428762419063
Receivables turnover: 22.916300710999582
Capitalized R&D asset: 22789870.24103982
ROCI (R&D-adjusted, %): 25.28684868458793
Rosenberg metric: 2.87218491028419
FCF margin (%): 26.841993598620256
Revenue growth (%): 163.59307400711742
Rule of 40 score: 190.4350676057377